Sunday, August 19, 2018
InDepth

InDepth

Critical analysis of various market situations that demand deep reviews is the primary feature of this section. It highlights the influential factors that guide demand or output, hinder or allow flow and finally the real inside picture.

Face to Face

“India will be Cepheid’s first manufacturing site outside US & Europe”

225
In an exclusive face to face interaction with the BioVoice, Mr Peter Farrell, Executive Vice President, Cepheid, and Mr Jai Shankar Krishnan, President & CEO, Danaher India shared the details about their companies' journey in India, TB elimination efforts and manufacturing plans...……..

Chat with BioVoice

“Categorization into phytopharma will encourage use of herbal drugs”

360
Mentioned Mr Amit Sharma, Director, Sanat Products in an exclusive interaction with the BioVoice where he shared details on the company's activities, regulations, outlook and much more...……………..